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Abstract 
Liquid Extraction Surface Analysis (LESA) is a new, high throughput tool for ambient mass 
spectrometry.  A solvent droplet is deposited from a pipette tip onto a surface and maintains contact 
with both the surface and the pipette tip for a few seconds before being re-aspirated.  The technique 
is particularly suited to the analysis of trace materials on surfaces due to its high sensitivity and low 
volume of sample removal.  In this work, we assess the suitability of LESA for obtaining detailed 
chemical profiles of fingerprints, oral fluid and urine, which may be used in future for rapid medical 
diagnostics or metabolomics studies.  We further show how LESA can be used to detect illicit drugs 
and their metabolites in urine, oral fluid and fingerprints.  This makes LESA a potentially useful tool in 
the growing field of fingerprint chemical analysis, which is relevant not only to forensics but also to 
medical diagnostics.   Finally, we show how LESA can be used to detect the explosive material RDX in 
contaminated artificial fingermarks. 
 
1. Introduction 
The relatively recent inception of ambient mass spectrometry methods such as desorption 
electrospray ionisation (DESI) [1, 2], plasma-assisted desorption ionisation (PADI) [3], direct analysis 
in real time (DART) [4] and paper spray mass spectrometry [5] has provided an exciting new capability 
for the high throughput analysis of many types of sample. Because the techniques generally do not 
require any form of sample preparation and can be carried out under ambient conditions, there has 
been considerable interest in their adoption for the analysis of biological fluids [6-8].  
  
Liquid Extraction Surface Analysis (LESA) [9-13] is a new tool in surface mass spectrometry, which also 
operates under ambient conditions and has recently become commercially available. The technique 
involves the deposition of a solvent droplet from a pipette tip onto a surface. The solvent droplet 
maintains contact with both the surface and the pipette tip for a defined time period (a few seconds) 
before being re-aspirated. The resulting sample can either be directly electrosprayed or subjected to 
further manipulation before mass spectrometry analysis. The technique consumes only a very small 
volume of sample, making it minimally destructive and suitable for the analysis of trace materials on 
surfaces. Because the analysis takes place under ambient conditions and does not require sample 
preparation, high throughput screening of samples is possible. In contrast to other ambient analysis 
techniques mentioned above, the process of surface sampling and ionisation are decoupled, offering 
opportunities for superior quantification. Whilst LESA has shown promise for the profiling of proteins, 
lipids, drugs and metabolites in tissue and blood [10-13], its potential application to the chemical 
profiling of other biological fluids has not yet been considered. 
Chemical profiling of biological fluids is a growing research area, with applicability to metabolomics, 
medical diagnostics, toxicologyand roadside drug testing.  For these applications a variety of biological 
matrices may be used or have been proposed for use, with complementary features. In medical 
diagnostics, urine is widely used for the detection of disease and for therapeutic drug monitoring [14]. 
In the forensics field, oral fluid is becoming the matrix of choice for roadside testing due to its non-
invasive nature, but is rapidly gaining acceptance as a suitable matrix for medical diagnostics [15-16].  
Another biological material of interest is a latent fingerprint.  The field of fingerprint chemical analysis 
is also a rapidly growing research area, starting from a recent paradigm shift in the forensic community 
for using fingerprints for more than just their ridge detail [21-29]. It has been previously shown that 
the chemical composition relates to the age of a latent fingerprint [28], the sex of the donor [24], their 
drug habits or medical history [17-20], the way they interact with development reagents [21] and 
might even be used to confirm their identity using their amino acid profile [29] or to verify their 
location on questioned documents [23]. This may be useful when a fingerprint is smudged or details 
of the donor are not contained within the fingerprint database. Many techniques have been proposed 
for these applications, including spectroscopic techniques [30], which lack the selectivity of mass 
spectrometry methods; chromatography based approaches [22,29] which require considerable 
sample preparation and consume at least an entire fingerprint; and vacuum based methods [20-25], 
which have lower sample throughput and have been shown to degrade fingerprint chemistry [31].  
Here, we show how LESA coupled to high resolution mass spectrometry can be used to rapidly detect 
a wide array of molecules, including ingested drugs and their metabolites, amino acids, fatty acids, 
peptides and other endogenous compounds in urine, oral fluid and fingerprint.  The wide array of 
compounds detected from a small sample make the technique an attractive approach for diagnostic 
assays of the future from any of these matrices.  
We also show how LESA can detect an explosive material in contaminated fingerprints. Finally, we will 
demonstrate how fingerprint analysis using LESA can be carried out in conjunction with higher 
resolution imaging methods (in this case Matrix Assisted Laser Desorption Ionisation Mass 
Spectrometry (MALDI)), for a more detailed review of compound distribution.  
 
  
2. Experimental 
Sample collection 
Latent fingerprints were obtained from an individual attending a drug and alcohol treatment service 
to receive treatment for drug dependence. "Natural" fingerprints were deposited onto glass 
microscope slides at a pressure between 400-1000 g and barcoded, before being shipped to the 
laboratory for analysis. Two corresponding oral fluid samples were collected from the patient using a 
Quantisaltm collection kit, Alere Toxicology, UK. One oral fluid sample was screened for amphetamines, 
benzodiazepines, cannabis, cocaine, methadone and opiates, using a standard immunoassay drug 
screening procedure at LGC Forensics, Teddington, Middlesex. The second was reserved for LESA 
analysis. A urine sample was also collected from the patient, using an LGC Forensics urine collection 
kit. Immediately prior to analysis, 0.2 µL drops of the oral fluid solution and the urine were spotted 
onto separate glass slides. The fingerprints, second oral fluid sample and the urine were stored in a 
fridge at 2-5oC and then allowed to reach room temperature prior to analysis. Reference spectra were 
collected from standards of cocaine, methylecgnonine (EME), benzoylecgonine (BZE), methadone, 2-
ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), 2-ethyl-5-methyl-3,3-diphenylpyrroline 
(EMDP), heroin and 6-acetylmorphine (6-AM) immediately prior to analysis. Drug and metabolite 
standards were purchased from Sigma Aldrich Limited, UK. A favourable ethical opinion for sample 
collection and analysis was granted from the UK National Research Ethics Service, reference 
14/LO/0346.  
Latent fingerprints were also collected from an additional female and a male volunteer who were not 
patients of the drug and alcohol treatment service. The hands of the volunteers were not washed prior 
to deposition of the fingerprints. A second female volunteer with no drug use history provided a 
sample of urine and oral fluid. 
To investigate the possibility of detecting exogenous compounds in fingerprints, artificial fingerprints 
with controlled contamination were prepared. A polymeric dummy finger was rubbed over forehead 
and cheek and subsequently loaded with explosives by rubbing the dummy over the explosive loaded 
tissue paper. Standard solutions (1 ml, 100 µg/ml) of TNT and RDX were absorbed on regular tissue 
paper, which was placed in a petridish. The tissue paper was wetted with approximately 2 ml of 
ethanol. The loaded dummy finger was subsequently placed on different microscope slides to make 
contaminated fingerprints. 
LESA  
 
Materials  
Methanol, ethanol and acetonitrile used in preparation of electrospray solvents were purchased from 
Fisher Scientific (Leicestershire, U.K.). Water was purified by an ELGA Option 3 system (Marlow, UK). 
Formic acid (FA) was purchased from Sigma-Aldrich Company Ltd. (Dorset, U.K.).  
 
 
Surface Sampling 
Automated sample analysis was performed using the LESA Points software (Advion Ithaca, NY), which 
controls the TriVersa Nanomate. This platform was used to select the sampling location (x and y co-
  
ordinates) and the z position, relative to the plate height, for sampling routines using the Nanomate 
probe. The LESA sampling routine involved the collection of a conductive tip from the Advion tip rack 
before moving to solvent well containing the electrospray solvent solution. The Nanomate probe 
aspirated a pre-set volume into the conductive tip. The probe relocated to the predetermined location 
on the surface then descended to 0.2 mm above the surface. The tip dispensed between 0.5 and 3 µL 
onto the sample forming a liquid micro-junction (LMJ) between the tip and the surface. The LMJ was 
maintained to allow sufficient time for analytes to be dissolved into the solution (1-3 seconds)). The 
solvent was then reaspirated into the tip (1-3 µL). Finally the tip was rotated and engaged with the 
back of the ESI chip, and nanospray ionization was initiated. The Triversa Nanomate was coupled with 
a Thermo Fisher Scientific Orbitrap Velos mass spectrometer.  
 
 Matrix Analyte  
 
Natural 
fingerprint saliva Urine Proteins 
 
explosives 
solvent composition 
solvent volume (µl) 
 
A 
3 
A 
0.7 
A 
0.7 
B 
2 
A 
3 
dispense (µl) 2 0.5 0.5 1 2 
delay (s) 3 2 2 1 2 
aspirate (µl) 3 0.8 0.8 2 3 
dispensation height (mm) 0.4 0.4 0.4 0.2 0.4 
aspiration height (mm) 0.2 0.2 0.2 0 0.2 
delivery time (min) 3 3 3 2.5 3 
gas pressure (psi) 0.3 0.3 0.3 0.3 0.3 
voltage (kV) 
Fill time 
1.4 
43 ms 
1.4 
9 ms 
1.4 
3 ms 
1.4 
43 ms 
1.4  
43 ms 
 
Table 1 : Optimised LESA methods used for analysis of fingerprints, saliva, explosives and proteins in 
fingerprints.  Solvent A = 70 : 30 Methanol : Water with 0.1% formic acid; Solvent B = 70:30 methanol 
: water with 2% formic acid;  
 
Mass Spectrometry 
Samples were introduced at a flow rate of ~80 nL/min with a gas pressure of 0.3 psi, a tip voltage of 
1.4 kV and a capillary temperature of 250 °C. MS data were collected in full scan mode at a resolution 
of 100 000 at m/z 400. Each scan comprised 3 co-added microscans. For all optimisation experiments 
the Automatic Gain Control (AGC) was used to accumulate sufficient ions for analysis. The AGC target 
was 1x106 with fill times as indicated in Table 1.  
 
Collision Induced Dissociation (CID) 
CID was performed in the linear ion trap with nitrogen gas at a normalised collision energy of 30%. 
Ions were detected in the Orbitrap at a resolution of 100,000 at m/z 400. The AGC target was 5x104 
with a maximum fill time of 2 s. Each scan comprised 1 microscan. The precursors selected and major 
product ion m/z values are listed in Table 2.  
 
Data processing 
Mass spectrometry data were analyzed using Xcalibur 2.10 software (Thermo Fisher Scientific) where 
the Xtract program was used to calculate monoisotopic masses. For all other data processing, data in 
  
the Thermo RAW format were converted to mzML using msconvert as part of ProteoWizard [32] 
Sequential spectra that corresponded to the same injection (as determined by time from the total ion 
chromatogram) were summed together and outputted to mzML using a custom MATLAB script. The 
summed spectra were then converted to imzML using imzMLConverter [33]. All further data 
processing was performed in MATLAB using in-house software.  
 
Spectra were queried for a compound of interest by extracting the region of the spectra that spanned 
20 ppm error either side of the accurate mass. Orthogonal matching pursuit (OMP) was then used to 
fit peaks to the reduced spectral region [34]. OMP was applied with 7 iterations and a dictionary 
composed of Gaussian functions (with standard deviation of 1) and an additional constraint that no 
fitted peaks could be within 1 standard deviation. The fitted peak with the lowest ppm error was 
assigned as a match.  
 
MALDI MS imaging 
Fingerprint samples were coated with CHCA matrix (5 mg/mL in 80% MeOH, 0.1% TFA) using a TM-
Sprayer (HTX Technologies, LLC). 8 coatings were deposited. The matrix was sprayed with a flow rate 
0.115 mL/min and track speed of 1333 mm/min. The capillary temperature was 90°C and the spacing 
between tracks was 3mm.  
MALDI MSI data were acquired with a QSTAR XL QqToF instrument with an oMALDI 2 ion source using 
Analyst QS 1.1 with oMALDI server 5.1 (AB Sciex). An Nd:YAG (Elforlight: FQS-200-1-Y-355) diode 
pumped solid state (DPSS) laser (Elforlight, Daventry, UK). The laser was triggered from the QSTAR XL 
instrument using the existing TTL trigger signal in conjunction with a function generator (Thurlby 
Thander Instruments, TG2000 20MHz DDS) triggering the laser at a repetition rate of 1000 Hz. Images 
were acquired at 100 x 100 μm, using a raster speed of 0.2 mm s-1. 
MALDI MS data were converted from proprietary file format to mzML using AB MS Data Converter 
(AB Sciex version 1.3) and then converted to imzML using imzMLConverter [33] and using in house 
software.  
 
Results and Discussion 
Chemical profiling of fingerprints, oral fluid and urine 
Full scan data for fingerprint, oral fluid and urine samples are shown in Figure 1.  The urine spectrum 
is dominated by the creatinine peak at m/z 114.  Table 2 shows the compounds searched for (taken 
from a list of previously detected substances in the review by Girod et al [26]) and the corresponding 
peaks detected in fingerprint, urine and oral fluid samples.  Other peaks are present at higher 
abundance in the spectra, but these could not be assigned. 
In the fingerprint, 17 amino acids were detected, together with 18 fatty acids and 12 miscellaneous 
substances. It is remarkable to detect this many substances in a single analysis of a fingerprint. The 
donor used here was female, and female donors are known to give particularly poor fingerprints [22], 
showing the great potential for this method for fingerprint chemical profiling. Previous reviews of 
  
fingerprint chemical profiling [22], [26] indicate that a range of analytical techniques have previously 
been required to survey such a wide range of compounds within a fingerprint. Table 2 shows how LESA 
coupled to mass spectrometry opens up the possibility of doing this within a single analysis.  Surveying 
such a large number of compounds in an individual fingerprint may assist future investigations 
designed to determine the age of a fingerprint, the identity of a donor from a smudged fingerprint, or 
indeed may permit medical diagnostics to be carried out from a fingerprint as a convenient sampling 
matrix. 
Analyte  
Monoisotopic 
Mass (M+H) 
Chemical 
Formula 
Fingerprint 
Oral 
Fluid 
Urine 
Amino Acids           
Glycine 76.0399 C2H5NO2 y ND ND 
Histidine 156.0773 C6H9N3O2 y √ √ 
Serine 106.0504 C3H7NO3 y √ √ 
Alanine 90.0555 C3H7NO2 y √ √ 
Isoleucine / leucine 132.1025 C6H13NO2 y √ √ 
Threonine 120.0661 C4H9NO3 y √ √ 
Arginine 175.1195 C6H14N4O2 y √ √ 
Tyrosine 182.0817 C9H11NO3 y √ √ 
Asparagine 133.0613 C4H8N2O3 ND √ √ 
Lysine 147.1134 C6H14N2O2 y √ √ 
Valine 118.0868 C5H11NO2 y √ √ 
Aspartic Acid 134.0453 C4H7NO4 y √ √ 
Methionine 150.0589 C5H11NO2S y ND √ 
Taurine 126.0225 C2H7NO3S y ND √ 
Citrulline 176.1035 C6H13N3O3 y √ √ 
Ornithine 133.0977 C5H12N2O2 y √ √ 
Glutamic Acid 148.061 C5H9NO4 y √ √ 
Phenylalanine 166.0868 C9H11NO2 y √ √ 
Fatty acids           
Octanoic acid (8:0)  145.123 C8H16O2 √ √ √ 
Nonanoic acid (9:0)  159.1387 C9H18O2 √ √ √ 
Decanoic acid (10:0)  173.1543 C10H20O2 √ √ √ 
Dodecanoic acid (12:0)  201.1856 C12H24O2 √ ND √ 
Tridecanoic acid (13:0)  215.2013 C13H26O2 ND ND ND 
Myristoleic acid (14:1)  227.2013 C14H26O2 √ ND ND 
Myristic acid (14:0)  229.2169 C14H28O2 √ ND √ 
Pentadecenoic acid (15:1) 241.2169 C15H28O2 √ √ ND 
Pentadecanoic acid (15:0) 243.2326 C15H30O2 √ √ √ 
Palmitoleic acid (16:1)  255.2326 C16H30O2 √ √ √ 
Palmitic acid (16:0)  257.2482 C16H32O2 √ √ √ 
Margaric acid (17:0)  271.2639 C17H34O2 √ √ √ 
Heptadecenoic acid (17:1) 269.2482 C17H32O2 √ ND √ 
Linoleic acid (18:2)  281.2482 C18H32O2 √ ND ND 
Oleic acid (18:1)  283.2639 C18H34O2 √ √ √ 
  
Stearic acid (18:0)  285.2795 C18H36O2 √   √ 
Nonadecanoic acid (19:0)  299.2952 C19H38O2 √ √ ND 
Eicosanoic acid (20:0)  313.3108 C20H40O2 √ ND ND 
Heneicosanoic acid (21:0)  327.3265 C21H42O2 ND ND ND 
Docosanoic acid (22:0)  341.3421 C22H44O2 √ ND ND 
Tricosanoic acid (23:0)  355.3578  C23H46O2 ND ND ND 
Tetracosanoic acid (24:0) 369.3734 C24H48O2 ND ND ND 
Miscellaneous           
caffeine 195.0882 C8H10N4O2 √ ND √ 
caffeine metabolite, 
Paraxanthine 
181.0726 C7H8N4O2 √ ND √ 
cholesterol 369.3521 C27H46O √ ND ND 
creatinine 114.0667 C4H7N3O √ √ √ 
squalene 411.3991 C30H50 √ ND ND 
phenol 95.0497 C6H6O √ √ √ 
riboflavin 377.1461 C17H20N4O6 y ND ND 
Uric Acid 169.0362 C5H4N4O3 √ ND √ 
Urea 61.0402 CH4N2O √ ND √ 
Lactic Acid 91.0395 C3H6O3 √ √ √ 
alpha-Tocopherol 431.3891 C29H50O2 y ND ND 
delta-Tocopherol  403.3578 C27H46O2 y ND ND 
 
Table 2: Compounds detected in a single fingerprint, a sample of urine (3 analyses) and a sample of 
oral fluid (3 analyses) using LESA; list taken from Girod et al [25]. √=detected with counts >3x the blank; 
ND = not detected 
Similarly, Table 2 demonstrates that an array of compounds including lipids, amino acids and other 
substances can be detected by LESA in urine and oral fluid.  This opens up the possibility of using LESA 
as a tool to rapidly probe an array of urine and oral fluid samples.  In biomarker discovery, the ability 
to survey a wide array of compounds without targeting particular species is key to a successful 
outcome.  Table 2 demonstrates the ability of LESA to do exactly this, at a comparatively high sample 
throughput compared with the chromatography methods that are conventionally used in these 
studies.  LESA coupled to high resolution mass spectrometry could therefore add significant value to 
future investigations in this area. 
 
Drugs in Biological Matrices 
Spectra acquired from LESA-MS analysis of fingerprint, oral fluid and urine samples collected from a 
donor without a drug use history did not reveal any peaks of interest for ions relating to cocaine, 
methadone, heroin and their respective metabolites.  
Analysis of Patient Samples 
Oral Fluid 
  
The patient’s oral fluid screened positive for cocaine and opiates using the LGC immunoassay test. 
LESA MS analysis of corresponding oral fluid sample indicated presence of cocaine, EME and BZE, 
corroborating results from immunoassay screening. However, heroin and 6-AM were not detected in 
oral fluid by LESA. The oral fluid was suspended in a buffer solution provided as part of the collection 
kit, which has the effect of considerably diluting the oral fluid sample. No extraction from the buffer 
was carried out prior to LESA, and this, or differing solubilities of analytes in LESA solvents, may explain 
the reason for the apparent lack of sensitivity of the LESA method to heroin in this matrix.  The 
sensitivity of LESA for oral fluid could be improved by repeated spotting and drying procedures to 
increase the volume of sample.  Methadone and its metabolites were not detected by either method 
in oral fluids. Methadone was selected for analysis because the patient was on a methadone 
treatment programme.  
Fingerprints 
CID spectra revealed detection of expected product ions, consistent with standards of cocaine, BZE, 
Heroin and 6-AM, in all four regions of the sampled fingerprint, in direct agreement with the LGC 
immunoassay test. EME was detected in 3 out of the 4 locations analysed. Example CID spectra are 
given in Figure 2. No ions relating to methadone or its metabolites were detected. Methadone was 
not detected via immunoassay measurement. There was therefore good agreement between the LESA 
fingerprint and immunoassay oral fluid screen for all analytes. 
Urine 
Cocaine, and associated metabolites, in addition to the 6-AM metabolite were successfully detected 
in the donor urine sample via LESA-MS and immunoassay. Unsuccessful detection of ions of heroin in 
the urine of the donor can be explained by a difference in the detection window (varying time of 
excretion post-administration) for the different matrices studied here.  Additionally, it has previously 
been shown that opiates are detected more readily in sweat than in urine [41].  
Once again, methadone and metabolites were not detected using either method in the patient’s urine. 
A failure to detect these compounds in any sample, by either method indicates that, perhaps, the 
patient had not in fact consumed methadone within a detectable window. Further work must be 
conducted to establish limits of detection and to better understand these issues. 
Table 3 summarises the data obtained from LESA-MS of the patient’s oral fluid, urine and fingerprints.  
Drug and 
associated 
metabolites 
Parent ion 
m/z 
detected 
(M+H)+ 
Δ ppm 
from 
accurate 
mass 
CID 
transitions: 
precursor → 
product ion  
Oral 
fluid 
immune 
assay 
screen 
Fingerprint 
(LESA) 
Oral 
Fluid  
(LESA) 
Urine  
(LESA) 
Cocaine 
 
EME 
BZE 
304.1538  
 
200.1272  
290.1377 
3.5 
 
5.3 
7.3 
304→272, 
182, 150, 82 
200→182, 82 
290→272, 
168, 150 
Y 
 
 
Y 
 
Y 
Y 
Y 
 
Y 
Y 
Y 
 
Y 
Y 
  
Methadone 
EMDP 
EDDP 
ND 
ND 
ND 
N/A ND 
ND 
ND 
N N 
N 
N 
N 
N 
N 
N 
N 
N 
Heroin 
 
6-AM 
370.1640  
 
328.1531  
3.9 
 
5.4 
370→328, 
310, 
211,193 
328→310, 
286, 
211,193,165 
Y 
(opiates) 
Y 
 
Y 
N 
 
N 
N 
 
Y 
Table 3 : Drug and metabolite compounds detected in fingerprint, oral fluid and urine samples from 
the same donor. Four points on a single fingerprint from a donor were chosen at random and analysed 
using LESA. Three 0.2 µL spots of oral fluid in a buffer solution and three 0.2 µL spots of urine were 
analysed; the table shows the samples in which the relevant parent and precursor ions were detected. 
ND = Not Detected 
A limitation of the LESA method for fingerprint chemical analysis is the lack of spatial resolution.  In 
drug testing cases it may be necessary to take a sample testing positive for a drug using LESA and to 
verify the location of a substance within a fingerprint ridge, if a higher level of confirmation is required.  
To investigate the potential of carrying out this type of analysis, MALDI images of the fingerprint which 
had previously been analysed using LESA are presented in Figure 3. The images (3b and 3c) of ions 
detected at m/z 638.6 and 550.6 clearly show the three areas sampled from this fingerprint using 
LESA, and allow the LESA sampling area to be determined. Figure 3d shows a MALDI MS/MS spectrum 
acquired during CID of m/z 304 for the area of the fingerprint highlighted in Figure 3a, showing the 
characteristic fragment ion for cocaine at m/z 182. The image of this fragment ion is presented as an 
inset, showing some ridge detail. Whilst MALDI has been used before in imaging mode on fingerprints 
spiked with cocaine [20] and in profiling mode to detect cocaine in the fingerprint of a drug user [19], 
this appears to be the first report of MALDI imaging of drugs in a fingerprint from a drug user.  Whilst 
quantification of substances in fingerprint residue using MALDI is known to be difficult to achieve [22], 
a two-step process of (a) quantification of a drug residue in a fingerprint using LESA, and then (b) 
imaging using MALDI would thereby provide quantification and visualisation of a drug metabolite 
within a fingerprint ridge. 
A different LESA method, as described in Table 1 was developed for the detection of peptides and 
proteins in fingerprints. Application of this method to a fingerprint from a male donor yielded the 
spectra presented in Figure 4. Several multiply charged ions are detected, indicating the potential of 
this method for profiling peptides and proteins directly in latent fingerprints. The spectrum presented 
in figure 4 shows detection of an ion at m/z 1434.68. This +6 charge state ion reveals that molecules 
of approximately 8600 daltons are detected using this method. Identifications of proteins and 
peptides in fingerprints have been made previously by others [26], most notably by Francese’s group 
[24] using MALDI. There are several possible advantages of using LESA compared to techniques such 
as MALDI. These advantages include improved sensitivity afforded by larger sampling regions; 
opportunities for using multiple fragmentation techniques within a single analysis (e.g. analysis of 
multiply charged ions can allow electron transfer dissociation (ETD) as well as CID to be used for 
improved sequence coverage); and long electrospray survey times achieved by using nano-
electrospray flow rates for analysis of microliter volumes, which allows for multiple fragmentation 
  
events. Previous research has shown how hundreds of proteins can be detected from digested tissues 
and blood spots using LESA coupled to LC/MS [35]. Introducing a chromatographic step into LESA-MS 
analysis of fingerprints, following sample digestion, will likely enable detection and identification of 
many proteins from a single location of a single fingerprint and will form the topic of further work.  
Detection of Explosives in a Contaminated Fingerprint 
Figures 5a shows full scan spectra collected during analysis of a standard of RDX.  The mass spectrum 
shows the presence of a peak at m/z 221.0255, which can be assigned to [M-H]- [36]. Figure 5b shows 
that this peak is also present in the fingerprint sample, and Figures 5c and d show that the peak is also 
not present in either the TNT standard (Figure 5c) or the fingerprints that were blank for RDX (but 
spiked with TNT) (Figure 5d).  In contrast, no peaks corresponding to TNT were found in the 
contaminated fingerprint sample, implying a lack of sensitivity to this compound, or that the 
compound was unstable in the fingerprint matrix.  However, for RDX, these results do demonstrate 
the possibility of using LESA to detect explosives in contaminated fingerprints.  Other mass 
spectrometry methods including Direct Analyte Probed nanoextraction (DAPNe) [37], Direct Analysis 
in Real Time [36], desorption electrospray ionisation (DESI) [6] and MALDI [38] have also been 
demonstrated for this application. LESA offers complementary features compared with MALDI and 
DESI as described above for proteins. In the case of explosive detection from fingerprints, the long 
electrospray time that LESA offers allows multiple CIDs to be carried out from a single spot, leaving 
the rest of the fingerprint untouched. This is significant if a range of explosive or drug substances are 
to be scanned for.  In contract to DAPNe, LESA probes a larger area (offering enhanced sensitivity) and 
has a robotic system for high throughput, automated analysis. Future work should explore the limits 
of detection of LESA for these analytes in a fingerprint matrix, compare with the other techniques that 
have been previously demonstrated to show promise for this application and explore the integration 
of LESA into the forensic workflow.  
 
Conclusions 
We have demonstrated the potential for LESA to rapidly gain qualitative information from a range of 
biofluid samples including urine, oral fluid and fingerprints. The detection of drugs and metabolites in 
the oral fluid, urine and fingerprints of drug users make LESA an interesting candidate for high 
throughput drug testing, because the absence of sample preparation and chromatography step 
decreases the time spent on sample handling and analysis. In contrast to other ambient techniques 
such as DESI, DART, PADI and paper spray, the process of surface sampling and ionisation is more 
clearly decoupled. This will likely provide an opportunity for superior quantification, and inclusion of 
multiple reference or internal standards, and will be considered for these analytes and sample types 
in further work. 
The broad array of compounds detected in a single fingerprint makes LESA a very attractive technique 
for the study of fingerprint chemistry, an area which is rapidly growing in forensic science, due to the 
possibility of determining fingerprint age as well as the identity of the donor and the development of 
superior development reagents.  We have shown that because the LESA method only consumes a 
small area of a fingerprint, it could be used in conjunction with imaging mass spectrometry methods 
  
(e.g. MALDI) which have limited quantitative capability, if confirmation is required that a particular 
substance is located within a fingerprint ridge.  
More broadly, this method of sampling a large number of compounds from either oral fluid, urine and 
fingerprints is  highly relevant to medical diagnostics and metabolomics, because an array of samples 
can be rapidly probed, allowing high throughput analysis to be carried out. 
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Figures 
 
 
 
Figure 1   Full scan mass spectra showing Liquid Extraction Surface Analysis (LESA) of (a) blank, 
(b) natural fingerprint (c) oral fluid  (d) urine  
 
 
  
 
Figure 2   Collision induced Dissociation (CID) spectra produced by liquid extraction surface 
analysis (LESA) analysis of a fingerprint from a donor attending a drug rehabilitation service, showing 
fragment ion peaks corresponding to (a) 6-AM (b) heroin (c) cocaine (d) benzolyecgonine (e) 
methylecgonine 
 
 
 
 
Figure 3 Matrix Assisted Laser Desorption Ionisation (MALDI) images of a fingerprint 
previously analysed using liquid extraction surface analysis (LESA).   (a) representation of the areas 
analysed by LESA; images of (b) m/z 638.6 and {c} m/z 550.6; (d) MS/MS spectrum acquired during 
CID of m/z 304 for the area of the fingerprint highlighted in the inset, showing the characteristic 
fragment ion for cocaine at m/z 182.  
  
 
 
 
Figure 4 Full scan mass spectrum produced by the “protein” LESA method developed for 
fingerprints in the range m/z 1300 to 1500  
 
 
Figure 5 Full scan spectra for standards of (a) RDX (c) TNT and artificial fingerprints 
contaminated with (b) RDX and (d) TNT 
 
